Suprasorb® Liquacel*

Hydroactive Fibre Dressing

Suprasorb® Liquacel reduces the risk of maceration by vertically absorbing and transferring exudate to the secondary dressing. Suprasorb® Liquacel gels on contact with wound exudate, trapping exudate, debris and bacteria.

As Suprasorb® Liquacel is easy to cut when dry, it is easy to apply/pack. It is equally simple to remove. When moist, Suprasorb® Liquacel can be readily removed in one piece. This minimises the risk of dressing residue being left in the wound.

* The properties mentioned above refer to the current in vitro data.

Product composition

cellulose fibres, cellulose ethyl sulfonate fibre





Suprasorb® Liquacel*

sterile, individually sealed
Dimensions (cm)REFShipping units
5 x 53343510/100
10 x 103343610/100
15 x 15334375/50
45 x 2334385/50

Fields of application

For the care of acute and chronic superficial or deep wounds with low to high levels of exudate


  • lower leg ulcers
  • pressure ulcers
  • diabetic ulcers
  • 2nd degree burns
  • lacerations, cuts and abrasions
  • traumatic wounds and wounds with a tendency to bleed, e.g. after surgical or mechanical debridement
  • skin graft donor sites

Wound healing stages:

  • Exudation phase
  • Granulation phase


  • helps to protect the wound edge and the skin surrounding the wound
  • effective exudate management promotes the healing process
  • simple to use when moist as can be removed in one piece
  • vertical absorption and transfer of exudate to the secondary dressing

To note

  • When dry, Suprasorb® Liquacel* can easily be cut to the size of the wound. The dressing should overlap the wound edges by approx. 1 cm.
  • Loosely pack deep wounds to 85% with rope and leave approx. 2.5 cm extending past the wound edges.

Dressing change interval:

  • To be determined by the attending physician based on the wound condition, level of exudate, and secondary dressing used, but no longer than 7 days.

*) The properties mentioned above refer to the current in vitro data.

*) The properties mentioned above refer to the current in vitro data.